Atropos Health, a Palo Alto, CA-based leader in providing physicians with research-grade real-world evidence at the point of care, closed a $14M Series A funding round.
The round was led by Breyer Capital with participation from Emerson Collective and Boston Millennia Partners. In conjunction with the funding, Emerson Collective’s Matt Bettonville and Breyer Capital will have seats on the Atropos Health board of directors.
The company will use the funds to expand its commercial team, further build on recent market traction, and continue to develop its oncology product.
Led by newly appointed CEO Brigham Hyde, PhD, Atropos Health is a developer of a physician consultation service powered by research-grade real-world data. Using millions of anonymized patient records, the company helps providers answer clinical questions that have fallen through the cracks of the evidence-based literature.
Existing President, Neil Sanghavi, and Chief Medical Officer, Dr. Saurabh Gombar, will remain in their current roles. Co-founder Nigam Shah, MD/PhD, recently appointed Chief Data Scientist at Stanford University, will remain on the board.